Pfizer | PFE - Créances Commerciales

Prix De L'Action
26.26
Variation Quotidienne
-0.22 -0.83%
Mensuellement
-5.44%
Annuel
7.58%
Q2 Prévisions
26.42




Créances Commerciales Changement Date
AbbVie USD 12.59B 180M 2025-12
Abbott USD 10.57B 171M 2025-12
ALKERMES USD 334.02M 21.08M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Bayer EUR 14.19B 720M 2025-12
Biogen USD 1.87B 17M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Coherus Biosciences USD 18.42M 232.08M 2025-12
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Glaxosmithkline GBP 10.45B 707.81M 2025-12
J&J USD 21.33B 3.72B 2025-12
Medtronic USD 6.36B 30M 2025-12
Merck USD 12.12B 596M 2025-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 190.46M 8.54M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
Sanofi EUR 397M 186.13M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Zoetis USD 1.59B 49M 2025-12